Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BLC1501

Bladder cancer mid-density tissue array, 75 cases/150 cores
Unstained: $210.00 Add to Cart
H&E (BLC1501s*): $210.00 Add to Cart

Microarray Panel:Urinary carcinoma tissue microarray, containing 70 cases of carcinoma and 5 cases of normal tissue, duplicated cores per case
Cores:150
Cases:75
Layout:15 cols × 10 rows
Core Diameter:1.1 mm
Thickness:4 µm
Quality Control:H&E, IHC anti-Cytokeratin
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 M 55 Bladder, urinary Chronic cystitis A01 Inflammatory
A2 2 M 53 Bladder, urinary Chronic cystitis A02 Inflammatory
A3 3 M 59 Bladder, urinary Chronic cystitis A03 Inflammatory
A4 4 M 69 Bladder, urinary Chronic cystitis A04 Inflammatory
A5 5 M 63 Bladder, urinary Chronic cystitis A05 Inflammatory
A6 6 M 27 Bladder, urinary Transitional cell carcinoma I A06 Malignant
A7 7 M 47 Bladder, urinary Transitional cell carcinoma I~II A07 Malignant
A8 8 M 45 Bladder, urinary Transitional cell carcinoma II A08 Malignant
A9 9 M 68 Bladder, urinary Adenocarcinoma III A09 Malignant
A10 10 M 74 Bladder, urinary Transitional cell carcinoma II A10 Malignant
A11 11 M 78 Bladder, urinary Transitional cell carcinoma II~III A11 Malignant
A12 12 M 76 Bladder, urinary Adenocarcinoma I~II A12 Malignant
A13 13 M 64 Bladder, urinary Transitional cell carcinoma III A13 Malignant
A14 14 M 59 Bladder, urinary Adenocarcinoma III A14 Malignant
A15 15 M 80 Bladder, urinary Transitional cell carcinoma II~III A15 Malignant
B1 16 M 55 Bladder, urinary Chronic cystitis B01 Inflammatory
B2 17 M 53 Bladder, urinary Chronic cystitis B02 Inflammatory
B3 18 M 59 Bladder, urinary Chronic cystitis B03 Inflammatory
B4 19 M 69 Bladder, urinary Chronic cystitis B04 Inflammatory
B5 20 M 63 Bladder, urinary Chronic cystitis B05 Inflammatory
B6 21 M 27 Bladder, urinary Transitional cell carcinoma I B06 Malignant
B7 22 M 47 Bladder, urinary Transitional cell carcinoma I~II B07 Malignant
B8 23 M 45 Bladder, urinary Transitional cell carcinoma II B08 Malignant
B9 24 M 68 Bladder, urinary Adenocarcinoma III B09 Malignant
B10 25 M 74 Bladder, urinary Transitional cell carcinoma II B10 Malignant
B11 26 M 78 Bladder, urinary Transitional cell carcinoma II~III B11 Malignant
B12 27 M 76 Bladder, urinary Adenocarcinoma I~II B12 Malignant
B13 28 M 64 Bladder, urinary Transitional cell carcinoma III B13 Malignant
B14 29 M 59 Bladder, urinary Adenocarcinoma III B14 Malignant
B15 30 M 80 Bladder, urinary Transitional cell carcinoma II~III B15 Malignant
C1 31 F 53 Bladder, urinary Transitional cell carcinoma I~II C01 Malignant
C2 32 M 37 Bladder, urinary Transitional cell carcinoma III C02 Malignant
C3 33 M 55 Bladder, urinary Transitional cell carcinoma I~II C03 Malignant
C4 34 M 50 Bladder, urinary Adenocarcinoma II C04 Malignant
C5 35 F 74 Bladder, urinary Adenocarcinoma III C05 Malignant
C6 36 M 96 Bladder, urinary Transitional cell carcinoma I~II C06 Malignant
C7 37 M 70 Bladder, urinary Transitional cell carcinoma III C07 Malignant
C8 38 M 52 Bladder, urinary Transitional cell carcinoma II C08 Malignant
C9 39 M 61 Bladder, urinary Transitional cell carcinoma III C09 Malignant
C10 40 M 41 Bladder, urinary Transitional cell carcinoma III C10 Malignant
C11 41 M 61 Bladder, urinary Transitional cell carcinoma III C11 Malignant
C12 42 M 71 Bladder, urinary Squamous cell carcinoma I~II C12 Malignant
C13 43 F 39 Bladder, urinary Transitional cell carcinoma III C13 Malignant
C14 44 M 60 Bladder, urinary Squamous cell carcinoma I C14 Malignant
C15 45 M 75 Bladder, urinary Transitional cell carcinoma III C15 Malignant
D1 46 F 53 Bladder, urinary Transitional cell carcinoma I~II D01 Malignant
D2 47 M 37 Bladder, urinary Transitional cell carcinoma III D02 Malignant
D3 48 M 55 Bladder, urinary Transitional cell carcinoma I~II D03 Malignant
D4 49 M 50 Bladder, urinary Adenocarcinoma II D04 Malignant
D5 50 F 74 Bladder, urinary Adenocarcinoma III D05 Malignant
D6 51 M 96 Bladder, urinary Transitional cell carcinoma I~II D06 Malignant
D7 52 M 70 Bladder, urinary Transitional cell carcinoma III D07 Malignant
D8 53 M 52 Bladder, urinary Transitional cell carcinoma II D08 Malignant
D9 54 M 61 Bladder, urinary Transitional cell carcinoma III D09 Malignant
D10 55 M 41 Bladder, urinary Transitional cell carcinoma III D10 Malignant
D11 56 M 61 Bladder, urinary Transitional cell carcinoma III D11 Malignant
D12 57 M 71 Bladder, urinary Squamous cell carcinoma I~II D12 Malignant
D13 58 F 39 Bladder, urinary Transitional cell carcinoma III D13 Malignant
D14 59 M 60 Bladder, urinary Squamous cell carcinoma I D14 Malignant
D15 60 M 75 Bladder, urinary Transitional cell carcinoma III D15 Malignant
E1 61 M 68 Bladder, urinary Adenosquamous carcinoma E01 Malignant
E2 62 F 34 Bladder, urinary Transitional cell carcinoma II E02 Malignant
E3 63 M 75 Bladder, urinary Adenocarcinoma I~II E03 Malignant
E4 64 M 66 Bladder, urinary Transitional cell carcinoma II E04 Malignant
E5 65 M 60 Bladder, urinary Transitional cell carcinoma I E05 Malignant
E6 66 M 56 Bladder, urinary Squamous cell carcinoma I~II E06 Malignant
E7 67 M 85 Bladder, urinary Transitional cell carcinoma III E07 Malignant
E8 68 M 67 Bladder, urinary Transitional cell carcinoma I~II E08 Malignant
E9 69 M 71 Bladder, urinary Transitional cell carcinoma II~III E09 Malignant
E10 70 F 54 Bladder, urinary Transitional cell carcinoma I~II E10 Malignant
E11 71 F 65 Bladder, urinary Transitional cell carcinoma I~II E11 Malignant
E12 72 M 57 Bladder, urinary Transitional cell carcinoma II~III E12 Malignant
E13 73 M 73 Bladder, urinary Transitional cell carcinoma I E13 Malignant
E14 74 M 67 Bladder, urinary Transitional cell carcinoma III E14 Malignant
E15 75 M 69 Bladder, urinary Transitional cell carcinoma I E15 Malignant
F1 76 M 68 Bladder, urinary Adenosquamous carcinoma F01 Malignant
F2 77 F 34 Bladder, urinary Transitional cell carcinoma II F02 Malignant
F3 78 M 75 Bladder, urinary Adenocarcinoma I~II F03 Malignant
F4 79 M 66 Bladder, urinary Transitional cell carcinoma II F04 Malignant
F5 80 M 60 Bladder, urinary Transitional cell carcinoma I F05 Malignant
F6 81 M 56 Bladder, urinary Squamous cell carcinoma I~II F06 Malignant
F7 82 M 85 Bladder, urinary Transitional cell carcinoma III F07 Malignant
F8 83 M 67 Bladder, urinary Transitional cell carcinoma I~II F08 Malignant
F9 84 M 71 Bladder, urinary Transitional cell carcinoma II~III F09 Malignant
F10 85 Bladder, urinary Transitional cell carcinoma I~II F10 Malignant
F11 86 F 65 Bladder, urinary Transitional cell carcinoma I~II F11 Malignant
F12 87 M 57 Bladder, urinary Transitional cell carcinoma II~III F12 Malignant
F13 88 M 73 Bladder, urinary Transitional cell carcinoma I F13 Malignant
F14 89 M 67 Bladder, urinary Transitional cell carcinoma III F14 Malignant
F15 90 M 69 Bladder, urinary Transitional cell carcinoma I F15 Malignant
G1 91 M 53 Bladder, urinary Mucinous adenocarcinoma G01 Malignant
G2 92 M 72 Bladder, urinary Transitional cell carcinoma II G02 Malignant
G3 93 M 67 Bladder, urinary Adenocarcinoma III G03 Malignant
G4 94 M 70 Bladder, urinary Squamous cell carcinoma II G04 Malignant
G5 95 M 41 Bladder, urinary Signet ring cell carcinoma G05 Malignant
G6 96 F 70 Bladder, urinary Transitional cell carcinoma I~II G06 Malignant
G7 97 M 45 Bladder, urinary Transitional cell carcinoma I G07 Malignant
G8 98 M 70 Bladder, urinary Transitional cell carcinoma I~II G08 Malignant
G9 99 M 48 Bladder, urinary Leiomyosarcoma G09 Malignant
G10 100 F 74 Bladder, urinary Transitional cell carcinoma III G10 Malignant
G11 101 M 37 Bladder, urinary Squamous cell carcinoma I~II G11 Malignant
G12 102 M 60 Bladder, urinary Adenocarcinoma II G12 Malignant
G13 103 M 52 Bladder, urinary Transitional cell carcinoma II G13 Malignant
G14 104 M 41 Bladder, urinary Squamous cell carcinoma I~II G14 Malignant
G15 105 M 55 Bladder, urinary Signet ring cell carcinoma G15 Malignant
H1 106 M 53 Bladder, urinary Mucinous adenocarcinoma H01 Malignant
H2 107 M 72 Bladder, urinary Transitional cell carcinoma II H02 Malignant
H3 108 M 67 Bladder, urinary Adenocarcinoma III H03 Malignant
H4 109 M 70 Bladder, urinary Squamous cell carcinoma II H04 Malignant
H5 110 M 41 Bladder, urinary Signet ring cell carcinoma H05 Malignant
H6 111 F 70 Bladder, urinary Transitional cell carcinoma I~II H06 Malignant
H7 112 M 45 Bladder, urinary Transitional cell carcinoma I H07 Malignant
H8 113 M 70 Bladder, urinary Transitional cell carcinoma I~II H08 Malignant
H9 114 M 48 Bladder, urinary Leiomyosarcoma H09 Malignant
H10 115 F 74 Bladder, urinary Transitional cell carcinoma III H10 Malignant
H11 116 M 37 Bladder, urinary Squamous cell carcinoma I~II H11 Malignant
H12 117 M 60 Bladder, urinary Adenocarcinoma II H12 Malignant
H13 118 M 52 Bladder, urinary Transitional cell carcinoma II H13 Malignant
H14 119 M 41 Bladder, urinary Squamous cell carcinoma I~II H14 Malignant
H15 120 M 55 Bladder, urinary Signet ring cell carcinoma H15 Malignant
I1 121 M 60 Bladder, urinary Squamous cell carcinoma I I01 Malignant
I2 122 M 50 Bladder, urinary Transitional cell carcinoma II I02 Malignant
I3 123 M 82 Bladder, urinary Transitional cell carcinoma II I03 Malignant
I4 124 M 61 Bladder, urinary Transitional cell carcinoma III I04 Malignant
I5 125 M 43 Bladder, urinary Transitional cell carcinoma I~II I05 Malignant
I6 126 M 61 Bladder, urinary Transitional cell carcinoma II~III I06 Malignant
I7 127 M 56 Bladder, urinary Transitional cell carcinoma II I07 Malignant
I8 128 M 69 Bladder, urinary Transitional cell carcinoma III I08 Malignant
I9 129 M 63 Bladder, urinary Adenocarcinoma II I09 Malignant
I10 130 M 45 Bladder, urinary Transitional cell carcinoma II I10 Malignant
I11 131 F 39 Bladder, urinary Transitional cell carcinoma I I11 Malignant
I12 132 M 89 Bladder, urinary Transitional cell carcinoma II I12 Malignant
I13 133 M 60 Bladder, urinary Transitional cell carcinoma II I13 Malignant
I14 134 M 56 Bladder, urinary Transitional cell carcinoma II~III I14 Malignant
I15 135 M 38 Bladder, urinary Transitional cell carcinoma I I15 Malignant
J1 136 M 60 Bladder, urinary Squamous cell carcinoma I J01 Malignant
J2 137 M 50 Bladder, urinary Transitional cell carcinoma II J02 Malignant
J3 138 M 82 Bladder, urinary Transitional cell carcinoma II J03 Malignant
J4 139 M 61 Bladder, urinary Transitional cell carcinoma III J04 Malignant
J5 140 M 43 Bladder, urinary Transitional cell carcinoma I~II J05 Malignant
J6 141 M 61 Bladder, urinary Transitional cell carcinoma II~III J06 Malignant
J7 142 M 56 Bladder, urinary Transitional cell carcinoma II J07 Malignant
J8 143 M 69 Bladder, urinary Transitional cell carcinoma III J08 Malignant
J9 144 M 63 Bladder, urinary Adenocarcinoma II J09 Malignant
J10 145 M 45 Bladder, urinary Transitional cell carcinoma II J10 Malignant
J11 146 F 39 Bladder, urinary Transitional cell carcinoma I J11 Malignant
J12 147 M 89 Bladder, urinary Transitional cell carcinoma II J12 Malignant
J13 148 M 60 Bladder, urinary Transitional cell carcinoma II J13 Malignant
J14 149 M 56 Bladder, urinary Transitional cell carcinoma II~III J14 Malignant
J15 150 M 38 Bladder, urinary Transitional cell carcinoma I J15 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Sorry, this tissue array cannot be compared to find overlapping cases.
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal